WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Weight-loss jabs could halve workplace sickness, study finds

Over 60 per cent of patients in the study did not need to contact their GP at all after nine months of weight loss jabs

Raccontata daindependent.co.uktheguardian.comdailymail.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
independent.co.ukStai leggendo1 mesi fa

Weight-loss jabs could halve workplace sickness, study finds

Over 60 per cent of patients in the study did not need to contact their GP at all after nine months of weight loss jabs

originale
dailymail.com1 mesi fa

Weight-loss jabs halve sickness absence and could ease pressure on NHS

It has led to renewed calls for the drugs to be made available on the NHS for everyone who could benefit as soon as possible.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 13 maggio 2026·independent.co.uk

    New daily pill may help people keep weight off after stopping jabs

    Orforglipron works by lowering blood sugar levels, slowing food digestion and reducing appetite

  2. venerdì 15 maggio 2026·theguardian.com

    Weight-loss jabs could halve sickness absence and ease strain on NHS, study suggests

    Research shows sick leave among patients prescribed GLP-1 injections over nine-month period reduced by 50%

theguardian.com1 mesi fa

Weight-loss jabs could halve sickness absence and ease strain on NHS, study suggests

Research shows sick leave among patients prescribed GLP-1 injections over nine-month period reduced by 50%

Leggi questa versione → originale
  • venerdì 15 maggio 2026·dailymail.com

    Weight-loss jabs halve sickness absence and could ease pressure on NHS

    It has led to renewed calls for the drugs to be made available on the NHS for everyone who could benefit as soon as possible.

  • venerdì 15 maggio 2026·independent.co.uk

    Weight-loss jabs could halve workplace sickness, study finds

    Over 60 per cent of patients in the study did not need to contact their GP at all after nine months of weight loss jabs